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To assess the diagnostic accuracy of 1,3-b-D-glucan (BDG) assay for diagnosing invasive fungal infections (IFI), we searched the Medline and Embase databases, and studies reporting the performance of BDG assays for the diagnosis of IFI were identified. Our analysis was mainly focused on the cutoff level. Meta-analysis was performed using conventional meta-analytical pooling and bivariate analysis. Our meta-analysis covered 28 individual studies, in which 896 out of 4214 patients were identified as IFI positive. The pooled sensitivity, specificity, diagnostic odds ratio, and area under the summary receiver operating characteristic (AUC-SROC) curve were 0.78 [95% confidence interval (CI), 0.75e0.81], 0.81 (95% CI, 0.80e0.83), 21 .88 (95% CI, 12.62e37.93), and 0.8855, respectively. Subgroup analyses indicated that in cohort studies, the cutoff value of BDG at 80 pg/mL had the best diagnostic accuracy, whereas in caseecontrol studies the cutoff value of 20 pg/mL had the best diagnostic accuracy; moreover, the AUC-SROC in cohort studies was lower than that in caseecontrol studies. The cutoff value of 60 pg/mL has the best diagnostic accuracy with the European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria as a reference standard. The 60 pg/mL cutoff value has the best diagnostic accuracy with the Fungitell assay compared to the BDG detection assay. The cutoff value of 20 pg/mL has the best diagnostic accuracy with the Fungitec Gtest assay, and the cutoff value of 11 pg/mL has the best diagnostic accuracy with the Wako assay. Serum BDG detection is highly accurate for diagnosing IFIs. As such, 60 pg/mL of BDG
Introduction
The incidence of invasive fungal infections (IFIs) has markedly increased in recent decades. IFIs are serious and can lead to life-threatening complications in some patients. Despite the development of new antifungal drugs, the mortality rate of IFIs remains high, especially among intensive care unit patients. 1, 2 Invasive aspergillosis (IA) and invasive candidiasis (IC) represent the majority of IFIs with attributable mortality of 30e40%. 3 1,3-b-D-Glucan (BDG) is a fungal-cell-wall polysaccharide released into the bloodstream of patients with IC, IA, and other IFIs, except invasive zygomycosis, cryptococcosis, and Blastomyces dermatitidis. 4, 5 Therefore, the detection of BDG is a very interesting tool for IFI diagnosis. The potential role of BDG has been acknowledged by its inclusion in the revised European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria definitions. 6 At present, there are at least three BDG detection assays developed: Fungitell (Associates of Cape Code, Inc., East Falmouth, MA, USA), Wako (Wako Pure Chemical Industries, Ltd., Tokyo, Japan), and Fungitec-G test (Seikagaku, Kogyo, Tokyo, Japan). However, the results of test performances have varied depending on different assay types, reference standards, and cutoff values. There are several systematic reviews 7, 8 about the accuracy of serum BDG assay for diagnosing IFI focusing on various factors, and some of them showed a good diagnostic accuracy of BDG for IFIs, yet excluded assessment of cutoff subgroups. In this article, we report a new systematic review assessing the diagnostic accuracy of serum BDG for IFIs on different cutoff values. We also focus on different assay types, reference standards, and study design for betweenstudy variability in diagnostic accuracy.
Methods
Search strategy and study selection
An overall search of the literature was performed by two investigators (H.S. and G.F.) using the following sources from inception through the end of June 2013: Medline database through PubMed (http://www.ncbi.nlm.nih.gov/ pubmed) and Embase through Scopus (http://www. scopus.com/home.url). The searching terms were: invasive fungal disease, IFD, invasive fungal infection, IFI, candidiasis, Candida, aspergillosis, Aspergillus, 1,3-b-Dglucan, b-D-Glucan, D-glucan, BG, and BDG. Only papers published in full text were selected, and the language was restricted to English.
We screened the reference lists and abstracts of related studies, and the full text of potentially relevant publications of clinical studies reporting measurement of serum BDG for the diagnosis of IFI were included if: (1) the test performed was a commercially available BDG assay with evaluation of the cutoff value for positivity recommended by the manufacturer: Fungitell, Fungitec-G, and Wako turbidimetric assay; (2) they used the EORTC/MSG criteria in 2002 or the revised EORTC/MSG criteria in 2008 (patients with proven and probable IFIs were considered true positive cases), 6, 9 histopathologic examination, microbiological culture, or autopsy as diagnostic criteria for classification of IFIs; and (3) data on true positive, true negative, false positive, and false negative results of the BDG test were reported separately or could be calculated from the manuscript. Corresponding authors were contacted for retrieval of complementary information as needed. Agreement among the three investigators (H.S., Z.L., and Z.D.) on the above criteria was required for inclusion in the analysis.
Data extraction and study quality assessment
The final set of articles was assessed by two reviewers (H.S. and H.J.). Disagreements were resolved by a third author (W.F.). From each of the included studies, we extracted data on publication year; name(s) and institution(s) of the author(s); information on the original sample source; study design; characteristics of control individuals; numbers of true positive, false negative, true negative, and false positive observations; type and manufacturer of the BDG assay; reference standards; cutoff values for definition of a positive BG test result; and blinding of investigators to results. If the article analyzed different BDG cutoff values, we chose the recommended cutoff value of author(s) for our meta-analysis. The number of healthy volunteers and individuals without risk factors was excluded, because they may lead to overestimation of diagnostic accuracy. 10 The methodological quality of the included studies was assessed by three authors (H.S., H.J., and Z.L.) with the QUADAS tool. 11 Eight of the 14 QUADAS items were considered relevant for our meta-analysis reference to another meta-analysis. 12 Each item was scored as "yes", "no'', or "unclear", and agreement of three authors was required.
Data synthesis and analysis
In order to obtain the outcomes, we performed a comparison to evaluate the diagnostic accuracy of the serum BDG assay for IFI with MetaDisc version 1.4 (http://www.hrc.es/ investigacion/metadisc_en.htm) based on the random-effects model. Then, we estimated the sensitivity, specificity, diagnostic odds ratio (DOR) with 95% confidence interval (95% CI), and area under the summary receiver operating characteristic curve (AUC-SROC) based on different cutoff values. If the subgroup only included one study, we calculated the above data using SPSS Statistics 20 (IBM, China). We also performed more stratified (subgroup) analyses to estimate the effects of study design, reference standard, and assay type if the subgroup included data of at least two diagnostic studies. We evaluated the degree of interstudy statistical heterogeneity using the test of inconsistency (I 2 ) 13 and the Chi-square test 14 with RevMan 5 (http://ims.cochrane.org/revman/about-revman-5). A p value <0.1 for the Chi-square test indicated the presence of statistical heterogeneity.
Results
Characteristics and quality assessment of the included studies
As a result of our bibliographical search in PubMed and Scopus, 28 individual studies that comparatively assessed the value of BDG testing for the diagnosis of IFI were included in our review, 1,15e41 including 4214 patients, of which 896 were identified as positive for IFIs with reference standards. The process used for the selection of studies that were eligible for inclusion is shown graphically in Fig. 1 .
The characteristics and data on the diagnostic performance of BDG assays for IFIs of the 28 included studies are shown in Table 1 . The 28 studies assessed different cutoff values at 7 pg/mL, 8.9 pg/mL, 10 pg/mL, 11 pg/mL, 20 pg/ mL, 30 pg/mL, 40 pg/mL, 60 pg/mL, 75 pg/mL, 80 pg/mL, 120 pg/mL, 140 pg/mL, and 1000 pg/mL of BDG for the diagnosis of IFIs. Among the 28 studies included in the meta-analysis, 15 had a cohort study design, 1,16,17,19e23,25,27,29,31,34,36,38 and the remaining 13 had a caseecontrol design. 15,18,24,26,28,30,32,33,35,37,39e41 Seventeen of the 28 studies used EORTC/MSG criteria as the reference standard, 1,15e20,23,24,27e29,31,33,34,36,38 two referenced autopsy reports, 26, 41 two used referenced histopathologic examination and microbiological culture, 21, 35 and seven referenced microbiological cultures only. 22, 25, 30, 32, 37, 39, 40 Among the 28 studies, 18 were performed with the Fungitell assay, 1,15e19,21e25,28e30,33e35,38 five with the Wako assay, 20, 27, 32, 36, 39 and five with the Fungitec G-test assay. 26, 31, 37, 40, 41 Table 2 presents our assessment of whether each of the 28 studies in our review satisfied the eight items of the QUADAS tool that were considered relevant to our review. All studies were performed with acceptable reference standard and avoided differential verification bias and incorporation bias. Overall, 96.43% (27/28) of the studies clearly described study selection criteria. Table 3 demonstrates the pooled analysis findings for sensitivity, specificity, DOR, and AUC-SROC of the BDG assay for IFIs focusing on various factors. The 28 analyzed studies provided, in total, BDG diagnostic data for 896 patients with IFIs and 3318 control individuals with other conditions. The bivariate meta-analysis resulted in an average sensitivity of BDG for the diagnosis of IFI of 0.78 (95% CI, 0.75e0.81) and an average specificity of 0.81 (95% CI, 0.80e0.83; Fig. 2) . Additionally, the DOR was 21.88 (95% CI, 12.62e37.93), and the AUC-SROC was 0.8855. The interstudy heterogeneity test of the 28 studies demonstrated that they were statistically significantly heterogeneous (c 2 Z 135.73, p < 0.00001, I 2 Z 80%; Table 3 ).
Diagnostic accuracy of BDG for IFI
In assessing the diagnostic accuracy for IFIs, there is only one study that covered each BDG cutoff value at 7 pg/mL, 27 8.9 pg/mL, 20 10 pg/mL, 40 25, 31 ; four studies with 60 pg/mL 19, 22, 33, 35 ; and 10 studies with 80 pg/mL. 15e18,23,24,28e30, 38 The pooled sensitivity, specificity, DOR, and AUC-SROC of the BDG assay for IFI of each cutoff value, and the results of test of heterogeneity are displayed in Table 3 . The cutoff value of 80 pg/mL was used for 1932 patients (45.85% of the total patients), of which 383 were identified as positive for IFIs, and the pooled sensitivity, specificity, DOR, and AUC-SROC were 0.73 (95% CI, 0.68e0.77), 0.81 (95% CI, 0.79e0.83), 15 .66 (95% CI, 8.45e29.03), and 0.8726, respectively. Because there was only one study focusing on most of the cutoff values, we divided the cutoff values into four grades: 20 (7 studies), >20 and 60 (7 studies), >60 and 80 (11 studies), and >80 (3 studies). The meta-analysis results of each grade are shown in Table 3 , and only the three studies in Grade 4 (cutoff value of >80 pg/mL) were not heterogeneous (c 2 Z 2.09, p Z 0.35, I 2 Z 5%). Among the 15 cohort studies 1,16,17,19e23,25,27,29,31,34,36,38 (accounting for 41.72% of the total number of patients), the pooled sensitivity, specificity, DOR, and AUC-SROC were 0. 
BDG assay for patients with Candida or Aspergillus infection
Of the 28 included studies, five studies provided specific data regarding the sensitivity of BDG assay for IC, 21, 22, 30, 32, 37 six studies provided data for IA, 1,15,17,34e36 and 13 studies provided the respective data regarding the sensitivity of BDG testing for both patients with IC and patients with IA 16,19,23,24,26e28,31,33,38e41 (all data shown in Table 4 ). The total data in Table 4 indicate that the performance of BDG testing for the detection of IC did not differ considerably from its performance for the detection of IA (Pearson c 2 Z 0.517, p Z 0.472).
Discussion
Our meta-analysis indicated that serum BDG measurement had a good diagnostic accuracy for the diagnosis of IFIs. In our main analysis, when comparing patients who had proven or probable IFIs with patients who did not have IFIs, the AUC-SROC was 0.8855. A value between 0.80 and 0.90 has traditionally been considered to indicate good diagnostic test accuracy, and a value >0.90 indicates a very high overall diagnostic accuracy of the test. We also assessed the diagnostic accuracy of different cutoff values of BDG for IFI. There are four levels of cutoff values (7 pg/mL, 40 pg/mL, 75 pg/mL, and 140 pg/mL) applied to 686 patients (16.28% of the total number of patients), with AUC-SROCs < 0.80. Fortunately, most cutoff values (accounting for 83.72% of the total number of patients) have a good diagnostic test accuracy, particularly at the level of 20 pg/mL, and a very high diagnostic accuracy with an AUC-SROC of 0.9943. When we divided the cutoff values into four grades, AUC-SROCs of 20 pg/mL and >80 pg/mL were 0.9510 and 0.9149, respectively, indicating a very high diagnostic accuracy of BDG for IFIs. However, the above findings should be interpreted in the light of the high statistical heterogeneity that we noted among the studies for all analyses. The potential sources of heterogeneity among the included studies are differences among cutoff levels, study design, reference standard, and BDG detection assays. Therefore, we performed stratified (subgroup) analyses focusing on these factors, and the results indicated that there was no heterogeneity in the total 2 Z 0%) and 60 pg/mL (c 2 Z 0.10, p Z 0.75, I 2 Z 0%), and five studies in caseecontrol study at 80 pg/mL (c 2 Z 3.82, p Z 0.43, I 2 Z 0%). The summary results of our overall analysis of serum BDG assay for diagnosing IFIs are similar to those in studies earlier systematically reviewed by Onishi and colleagues, 7 who also analyzed the accuracy focusing on various factors except the cutoff level. Our review mainly focused on the differences between cutoff values, and it may be recognized as a supplement to the earlier review; moreover, we estimated the differences among the study design, reference standards, and BDG detection assays on the cutoff level. The analysis of cohort studies indicated that the cutoff value of BDG at 80 pg/mL had the best diagnostic accuracy (with an AUC-SROC of 0.9284), whereas the caseecontrol studies indicated that the cutoff value of 20 pg/mL had the best diagnostic accuracy (with an AUC-SROC of 0.9943), and the AUC-SROC in cohort studies was lower than that in caseecontrol studies. When using EORTC/MSG criteria as a reference standard, the cutoff value of 60 pg/mL has the best diagnostic accuracy, with an AUC-SROC of 0.8804. Regarding BDG detection assay types, the cutoff value of 60 pg/mL has the best diagnostic accuracy with the Fungitell assay (AUC-SROC Z 0.8973), the cutoff value of 20 pg/mL has the best diagnostic accuracy with the Fungitec G-test assay (AUC-SROC Z 0.9943), and the cutoff value of 11 pg/mL has the best diagnostic accuracy with the Wako assay (AUC-SROC Z 0.9575).
The present study has several limitations. First, the quality of the included studies was moderate and differed in many of their characteristics, which is commonly observed in diagnostic test accuracy reviews. It cannot be excluded that the accuracy of BDG testing for the diagnosis of IFI may differ between different patient groups. Second, this study included only full-text and English articles, which may lead to some high-quality studies being excluded from the analysis. The results of this study require more high-quality studies for confirmation in the future.
In conclusion, our meta-analysis suggests that measuring serum BDG levels has a good accuracy in distinguishing patients with IFIs, from patients without IFIs, mainly due to Candida and Aspergillus; the performance of BDG testing for the detection of IC did not differ considerably from its performance for the detection of IA; the cutoff value of 60 pg/mL has the best diagnostic accuracy with EORTC/MSG criteria as the reference standard; and the cutoff value of 60 pg/mL has the best diagnostic accuracy with the Fungitell assay, which was approved in 2003 by the United 
